Stock Research: ImmunoPrecise Antibodies

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

ImmunoPrecise Antibodies

TSXV:IPA CA45257F2008
94
  • Value
    39
  • Growth
    91
  • Safety
    Safety
    22
  • Combined
    89
  • Sentiment
    69
  • 360° View
    360° View
    94
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research company. It is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. It is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 94 (better than 94% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock ImmunoPrecise Antibodies are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for ImmunoPrecise Antibodies. The consolidated Growth Rank has a good rank of 91, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 91% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 69, which means that professional investors are more optimistic about the stock than for 69% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 22, which means that the share price of ImmunoPrecise Antibodies is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 78% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 39, which means that the company has a financing structure that is riskier than those of 61% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 86 73 87
Growth
91 35 59 65
Safety
Safety
39 39 4 13
Sentiment
69 43 82 3
360° View
360° View
94 94 70 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
67 73 54 29
Opinions Change
82 50 100 2
Pro Holdings
n/a 31 31 31
Market Pulse
58 17 43 42
Sentiment
69 43 82 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 86 73 87
Growth
91 35 59 65
Safety Safety
39 39 4 13
Combined
89 89 51 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
52 52 52 52
Price vs. Earnings (P/E)
38 89 78 66
Price vs. Book (P/B)
20 91 72 77
Dividend Yield
1 1 1 1
Value
22 86 73 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 45 63 47
Profit Growth
93 55 90 56
Capital Growth
1 58 49 91
Stock Returns
99 9 11 23
Growth
91 35 59 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
39 50 53 54
Refinancing
25 12 13 25
Liquidity
1 1 4 18
Safety Safety
39 39 4 13

Similar Stocks

Discover high‑ranked alternatives to ImmunoPrecise Antibodies and broaden your portfolio horizons.

Russel Metals

TSX:RUS
Country: Canada
Industry: Trading & Distribution
Size: Medium
Full Stock Analysis

Canadian Utilities

TSX:CU
Country: Canada
Industry: Multi-Utilities
Size: Medium
Full Stock Analysis

Whitecap Resources

TSX:WCP
Country: Canada
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

The North West

TSX:NWC
Country: Canada
Industry: Food Retail
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.